Impact Factor
4.29
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.16
1,944 total citations
h5-index
53
h5 depth signal
Cited share
83.7%
247 of 295
Total citations
1,944
Citation footprint
Metric signal
7.23
External metric anchor
Self-citation
3.7%
71 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
794
United States
191
Japan
184
India
181
South Korea
129
Citing Fields of Research
Hepatitis
723
Liver Diseases
697
Liver & Colon Cancer
285
Immunology
92
Transplantation
76
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,136
Articles tracked across the journal lifetime
Indexed publication set
295
247 cited publications
Last 12 months
233
19.4 publications/month
Open access share
19.3%
45 OA publications in the last year
Leading citing country
China
794 citing publications
Leading citing field
Hepatitis
723 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v9n1, Jan. 2015-
v1n1, Mar. 2007-v5n2, June 2011; selected citations only after this date ; v9n1, Jan. 2015-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hepatitis
Liver Diseases
Liver & Colon Cancer
Issuing & Sponsoring Bodies
Contributor
Asian Pacific Association for the Study of the Liver
Broad Categories
Gastroenterology
Hepatitis
Liver & Colon Cancer
Liver Diseases
MeSH Descriptors
Liver Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1007/s12072-026-11162-9
Open DOI
Diverging rate and absolute burden patterns of liver cancer attributable to NASH: global evidence and China as a sentinel case
Background The Global Burden of Disease Study (GBD) category "liver cancer due to non-alcoholic steatohepatitis" is modeled, rather than clinically adjudicated. We quantified this burden and tested whether declining age-standardized rate...
04
05
DOI 10.1007/s12072-026-11154-9
Open DOI
Exploratory analysis of transcriptionally active HBV-host chimeric transcript burden in patients with increasing HBsAg during long-term antiviral therapy
Background and aims: The longitudinal relationship between transcriptionally active hepatitis B virus (HBV) integration dynamics and serum hepatitis B surface antigen (HBsAg) during long-term antiviral therapy remains unclear. Methods: P...
06
DOI 10.1007/s12072-026-11161-w
Open DOI
Characteristic geoepidemiology and phenotype of autoimmune hepatitis: an 8-year population-based study in Taiwan
07
08
DOI 10.1007/s12072-026-11129-w
Open DOI
APASL Oncology 2026 Tokyo
09
DOI 10.1007/s12072-026-11153-w
Open DOI
Randomised trial of lifestyle interventions for improving metabolic dysfunction-associated steatotic liver disease
Background and aims: Lifestyle modification is the cornerstone of treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). To date, no published randomised controlled trials (RCTs) have provided a direct, head-to-h...
10
DOI 10.1007/s12072-026-11152-x
Open DOI
Clinical and pathological significance of serum anti-PD-1 autoantibodies in acute-onset and chronic autoimmune hepatitis
Background: Acute-onset autoimmune hepatitis (A-AIH) poses diagnostic challenges because autoantibodies are frequently absent or serum IgG levels may only be mildly elevated. Autoantibodies against the immune checkpoint molecule PD-1 hav...
Bibliographical & Catalog Notes
Description based on first issue; title from cover.
Also issued online.